Advertisement
Advertisement
GLPG
Galapagos NV
29.28
USDSponsored
+0.42
+1.46%
Apr 17, 16:00 UTC -4
Closed
After-Market
29.30
+0.02
+0.05%
GLPG Earnings Reports
Positive Surprise Ratio
GLPG beat 25 of 38 last estimates.
66%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$71.23M
/-$0.51
Implied change from Q4 25 (Revenue/ EPS)
-92.09%
/-104.30%
Implied change from Q1 25 (Revenue/ EPS)
-5.00%
/-78.11%
Galapagos NV earnings per share and revenue
On Feb 24, 2026, GLPG reported earnings of 11.87 USD per share (EPS) for Q4 25, beating the estimate of 2.76 USD, resulting in a 329.90% surprise. Revenue reached 900.82 million, compared to an expected 83.57 million, with a 977.98% difference. The market reacted with a -0.99% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.51 USD, with revenue projected to reach 71.23 million USD, implying an decrease of -104.30% EPS, and decrease of -92.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
NovaBridge Biosciences - ADR
Report Date
Apr 07, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.28
Surprise
-421.58%
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
FAQ
What were Galapagos NV's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Galapagos NV reported EPS of $11.87, beating estimates by 329.9%, and revenue of $900.82M, 977.98% above expectations.
How did the market react to Galapagos NV's Q4 2025 earnings?
The stock price moved down -0.99%, changed from $34.36 before the earnings release to $34.02 the day after.
When is Galapagos NV expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Galapagos NV's next earnings report?
Based on --
analysts, Galapagos NV is expected to report EPS of -$0.51 and revenue of $71.23M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement